A pioneering new biomaterial for the treatment of osteoporosis has been developed by a scientific team with the participation of biologists from Samara University. According to the researchers, the practical application of this material will allow recovery of not only the lost mineral components of bone tissue, but also organic ones.
Osteoporosis is a chronic disease accompanied by a progressive reduction in the mineral density of bone tissue. It causes increased bone fragility and the risk of bone fracture. According to scientists, osteoporosis is the fourth most deadly illness after cardiovascular diseases, cancer and diabetes.
The research team from Samara National Research University, Samara State Medical University and the International Interuniversity Research Laboratory for Tissue Engineering (IIRL TE) has developed a unique new material for the correction of osteoporosis treatment – Hydroxyapatite (HAp), obtained using a patented technology “Lioplast”.
According to the professor, the technology for obtaining HAp was improved and its quality evaluated using the Advanced Raman Spectroscopy Method. The researchers noted that there are no analogues of such materials for the treatment of osteoporosis in the world.
Scientists also reported that they carried out experimental studies on the composition of bone in osteoporosis, having analysed specific features of bone structure changes in different osteoporosis variants ranging from primary to secondary.
According to the researchers, the obtained results allow the development of set of methods for assessing the individual state of bone tissue at the pre-clinical stage in the application of new biomaterial (HAp) to prevent osteoresorption (resorption of bone tissue) in terrestrial conditions as well as in micro-gravity.
Zero gravity during space flight causes a specific loss of bone mass, leading to osteoporosis.
The results of the study were published in the Journal of Optical Technology.
0.00 (0%) 0 votes